Short interest for CME Gr gives investors a sense of the degree to which investors are betting on the decline of CME Gr's stock. Short interest data is updated every two weeks.

CME Gr Stock (NASDAQ:CME), Short Interest Report

CME Gr

Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The CME was founded in 1898 and in 2002 completed its initial public offering. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival, CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX in 2018, it has also expanded into cash foreign exchange, fixed income trading, and collateral optimization.

Bull Wall Street

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Large Cap

Macro Notification

Market Summary

Mid Cap

Bonds

Broad U.S. Equity ETFs

Commodities

Small Cap

Treasuries

Economics

Tech

ETFs

$BTC

BIIB

SPDR Dow Jones Industrial Average ETF Trust

LRCX

ODFL

ORLY

STLD

iShares Trust Barclays 20+ Year Treasury Bond Fund

Select Sector SPDR-Consumer Discretionary

Rising Treasury yields have investors cautious despite positive news from the earnings season.



The yield on the long-dated 30-year Treasury bond has surged to 4.79%. It’s on track to close at the highest level since early November, ahead of crucial economic data on Thursday.

Treasury Yields Rise, Tesla Jumps On Cheaper Model Pledge, Yen Plummets To 34-Year Lows: What&#39;s Driving Markets Wednesday?

News

Education

Markets

General

NVDA

SMCI

Trendless Markets are an Investor&#39;s Worst Nightmare

Cracking the Code: 5 Reasons a Choppy Market Looms

Federal Reserve

Trading Ideas

COST

PSMT

Markets are preparing for the coming interest rate cycle proposed by the Federal Reserve (the Fed). Though most sectors have priced in this potential pivot, some have yet to reflect this trend higher. Over the past six months, the Consumer Discretionary Select Sector SPDR Fund (ARCA:XLY) underperformed the broader S&amp;P 500 by as much as 11%.

Institutions Think This Consumer Stock Could Break Higher

CME Group Inc

CHINA MEIDONG AUTO HLDGS by China Meidong Auto Hldgs

China MeiDong Auto Holdings Ltd

CoinMerge (BEP-20)

CMONEY INC by cMoney, Inc.

CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) has outperformed the market over the past 20 years by 3.72% on an annualized basis producing an average annual return of 11.61%. Currently, CME Gr has a market capitalization of $75.48 billion. 
Buying $1000 In CME: If an investor had bought $1000 of CME stock 20 years ago, it would be worth $8,886.06 today based on a price of $209.64 for CME at the time of writing.
<h3>CME Gr's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1714509021_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In CME Gr 20 Years Ago Would Be Worth This Much Today

Barclays analyst Benjamin Budish maintains CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Equal-Weight and raises the price target from $226 to $228.

Price Target

Analyst Ratings

Barclays Maintains Equal-Weight on CME Gr, Raises Price Target to $228

B of A Securities analyst Craig Siegenthaler maintains CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Neutral and raises the price target from $209 to $216.

B of A Securities Maintains Neutral on CME Gr, Raises Price Target to $216

JP Morgan analyst Kenneth Worthington maintains CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Neutral and raises the price target from $198 to $206.

JP Morgan Maintains Neutral on CME Gr, Raises Price Target to $206

Keefe, Bruyette &amp; Woods analyst Kyle Voigt maintains CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Market Perform and raises the price target from $222 to $226.

Keefe, Bruyette & Woods Maintains Market Perform on CME Gr, Raises Price Target to $226

7 analysts have expressed a variety of opinions on CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $221.0, a high estimate of $245.00, and a low estimate of $187.00. Observing a 0.91% increase, the current average has risen from the previous average price target of $219.00. 
<img src="https://www.benzinga.com/files/images/story/2024/1714046418_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The standing of CME Gr among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Andrew Bond</td>
<td>Rosenblatt</td>
<td>Raises</td>
<td>Sell</td>
<td>$187.00</td>
<td>$185.00</td>
</tr>
<tr>
<td>Mike Cyprys</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$225.00</td>
<td>$222.00</td>
</tr>
<tr>
<td>Benjamin Budish</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$226.00</td>
<td>$225.00</td>
</tr>
<tr>
<td>Brian Bedell</td>
<td>Deutsche Bank</td>
<td>Lowers</td>
<td>Hold</td>
<td>$210.00</td>
<td>$235.00</td>
</tr>
<tr>
<td>Kyle Voigt</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Maintains</td>
<td>Market Perform</td>
<td>$229.00</td>
<td>-</td>
</tr>
<tr>
<td>Kevin Heal</td>
<td>Argus Research</td>
<td>Raises</td>
<td>Buy</td>
<td>$245.00</td>
<td>$225.00</td>
</tr>
<tr>
<td>Benjamin Budish</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$225.00</td>
<td>$222.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to CME Gr. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of CME Gr compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for CME Gr's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into CME Gr's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CME/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on CME Gr analyst ratings.</a>
<h2>About CME Gr</h2>
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The CME was founded in 1898 and in 2002 completed its initial public offering. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival, CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&amp;P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&amp;P futures contracts. Through CME's acquisition of NEX in 2018, it has also expanded into cash foreign exchange, fixed income trading, and collateral optimization.
<h3>CME Gr: A Financial Overview</h3>
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
Revenue Growth: CME Gr's revenue growth over a period of 3 months has been noteworthy. As of 31 December, 2023, the company achieved a revenue growth rate of approximately 19.17%. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Financials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 55.88%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): CME Gr's ROE excels beyond industry benchmarks, reaching 2.93%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): CME Gr's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.63%, the company may face hurdles in achieving optimal financial returns.
Debt Management: CME Gr's debt-to-equity ratio is below the industry average at 0.13, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>How Are Analyst Ratings Determined?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Deep Dive Into CME Gr Stock: Analyst Perspectives (7 Ratings)

Rosenblatt analyst Andrew Bond reiterates CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Sell and raises the price target from $185 to $187.

Reiteration

Rosenblatt Reiterates Sell on CME Gr, Raises Price Target to $187

Rising Treasury yields have investors cautious despite positive news <a href="https://www.benzinga.com/calendars/earnings">from the earnings season.</a>
The yield on the long-dated 30-year Treasury bond has surged to 4.79%. It&#8217;s on track to close at the highest level since early November, ahead of crucial economic data on Thursday.
The iShares 20+ Year Treasury Bond ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLT#NASDAQ">TLT</a>) fell 0.9%, extending its year-to-date drop to 10%. 
Rising yields are propelling the greenback higher, particularly against the low-yielding Japanese yen which tumbled to past 155 per dollar, hitting the lowest level since June 1990.
Tesla Inc. posted lower-than-expected results last quarter, but shares rose 10%. Investors reacted to the automaker&#8217;s pledge to produce more affordable models to broaden the market.
The S&amp;P 500 fell 0.4% by midday trading in New York; the tech-heavy Nasdaq 100 managed to hold steady; and small caps saw wider declines, with the iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) down 1%. 
Gold remains unchanged, while oil prices edged up by 0.5%, despite the Energy Information Administration revealing a 6.368 million barrel drop in crude oil inventories last week, significantly below market expectations of a 1.6 million barrel increase.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) fell 2.7% to $64,500 amid waning sentiment towards riskier assets. 
<h3 class="wp-block-heading">Wednesday&#8217;s Performance In Major US Indices, ETFs</h3>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day %chg</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>17,470.46</td>
<td>0.0%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>38,334.54</td>
<td>-0.4%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,048.09</td>
<td>-0.4%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>1,983.56</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 12:35 p.m. EDT</figcaption></figure>
The&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) fell 0.5% to $503.45, the&nbsp;SPDR Dow Jones Industrial Average (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) fell 0.4% to $383.43 and the tech-heavy&nbsp;Invesco QQQ Trust&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) inched 0.1% lower to $424.43, according to&nbsp;<a href="https://pro.benzinga.com/dashboard">Benzinga Pro data</a>.&nbsp;
Sector-wise, the Consumer Discretionary Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>) outperformed, up 0.3%. The Industrials Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLI#NYSE">XLI</a>) was the major laggard, down 1.5%. 
<h3 class="wp-block-heading">Wednesday&#8217;s Stock Movers</h3>
<ul>
<li>Texas Instruments Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>) rose 6.5%, after beating both earnings and revenue estimates last quarter. </li>
<li>Other companies reacting to earnings were Steel Dynamics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STLD#NASDAQ">STLD</a>) (down 2.5%), Mattel, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAT#NASDAQ">MAT</a>) (up 3.6%), Baker Hughes Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKR#NASDAQ">BKR</a>) (down nearly 2%), Chubb Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CB#NYSE">CB</a>), (down over 3%), Old Dominion Freight Line, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODFL#NASDAQ">ODFL</a>) (down over 10%), Norfolk Southern Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSC#NYSE">NSC</a>) (down 5%), Boston Scientific Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>) (up over 6%), AT&amp;T Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/T#NYSE">T</a>) (up 1.8%), Boeing Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) (down 1.6%), CME Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) (down 1.4%), General Dynamics Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GD#NYSE">GD</a>) (down 3.2%) and Hilton Worldwide Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLT#NYSE">HLT</a>) (up 4.3%). </li>
<li>Notable names reporting after the close are Whirlpool Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WHR#NYSE">WHR</a>), Western Union Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WU#NYSE">WU</a>), ServiceNow, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>), QuantumScape Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QS#NYSE">QS</a>), O&#8217;Reilly Automotive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORLY#NASDAQ">ORLY</a>), Meta Platforms, Meritage Homes Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTH#NYSE">MTH</a>), Lam Research Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRCX#NASDAQ">LRCX</a>), Knight-Swift Transportation Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNX#NYSE">KNX</a>), International Business Machines Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>), Ford Motor Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) and Chipotle Mexican Grill, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMG#NYSE">CMG</a>).</li>
</ul>
Now Read: <a href="https://www.benzinga.com/economics/macro-economic-events/24/04/38410454/treasury-yields-reach-5-month-high-lift-mortgage-rates-expert-warns-federal-debt-">Treasury Yields Reach 5-Month High, Lift Mortgage Rates; Expert Warns &#8216;Federal Debt Blob Is Out Of Control&#8217;</a>

Treasury Yields Rise, Tesla Jumps On Cheaper Model Pledge, Yen Plummets To 34-Year Lows: What's Driving Markets Wednesday?

CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) reported quarterly earnings of $2.50 per share which beat the analyst consensus estimate of $2.45 by 2.04 percent. The company reported quarterly sales of $1.50 billion which beat the analyst consensus estimate of $1.48 billion by 1.27 percent. This is a 4.05 percent increase over sales of $1.44 billion the same period last year.

Earnings

Earnings Beats

CME Gr Q1 2024 Adj EPS $2.50 Beats $2.45 Estimate, Sales $1.50B Beat $1.48B Estimate

Trendless Markets are an Investor&#39;s Worst Nightmare
Over my two-decade active investing career, I have learned valuable lessons by studying my trading history extensively. In looking back at my investments and the investing environment when I made the investment, I learned unsurprisingly that my best results came during bull markets (defined by the S&amp;P 500 Index trending above its 50-day moving average). Because about 75% of a stock&#39;s performance is correlated to the general market&#39;s direction, the results of my post-analysis make sense. However, the most surprising takeaway from my historical study of my trading history was that I did not lose the most money in bear markets. Instead, the biggest drawdowns in my equity curve occurred during trendless, choppy markets (as defined by the S&amp;P 500 Index stuck between the intermediate-term 50-day moving average and the long-term 200-day moving average.)
Don&#39;t only take my word for it; listen to two investing juggernauts from completely entirely different eras:
Jesse Livermore, who amassed his massive fortune during the Great Depression crash of 1929, warned of trendless markets by saying, &quot;There is a time to go long, a time to go short, and a time to go fishing.&quot;
Similarly, Ed Seykota, a trend following pioneer with a money management track record of ~60% annually net of fees over 30 years, felt so strongly about trendless markets that he composed his own tune appropriately named &quot;The Whipsaw Song.&quot;
While amateur investors seek to extract money from the market regardless of conditions, elite investors understand the importance of sitting on their hands and waiting patiently for a trend to develop. For equity investors, five items suggest that a trendless market may be in the works over the next few months, including:
Seasonality: Sell in May and Go Away?
Historical seasonality trends dating back to 1949 indicate that the S&amp;P 500 Index tends to fluctuate in election years until June before rallying into year end.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/f0/65561.png?v=1236224273" /> 
Image Source: Almanac Trader
Geopolitical Uncertainty
As the Russia/Ukraine war drags on, tensions between Iran and Israel have escalated recently. Though the tit-for-tat between the adversaries appears to be over in the short-term, the cloud of war continues to hang over equity markets and could lead to a &quot;headline-driven&quot; market.
Sentiment Bearish, But Room Lower
Sentiment indicators suggest that investors have one foot out the door. Despite the relatively tame pullback in the S&amp;P 500 Index, sentiment has shifted from &quot;Extreme Greed&quot; to &quot;Fear&quot; in just a handful of days. While the poor sentiment is bullish from a contrarian perspective, there is room to go lower in the next few months.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/f5/65562.png?v=975948455" /> 
Image Source: CNN
Muddled Fed Policy Picture
Wall Street&#39;s interest rate expectations have fluctuated dramatically as several Fed officials have opposing views, inflation remains stubborn, and commercial real estate concerns loom. For example, the Chicago Mercantile Exchange (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cme#NASDAQ">CME</a>) &quot;FedWatch&quot; tool gives the odds of a rate cut and no change in rates for July at around a coin flip. Because Fed liquidity is a significant market driver, the uncertainty around monetary policy may lead to uncertainty in equities.
Digestion Pullbacks are Normal 
Nvidia (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvda#NASDAQ">NVDA</a>), Super Micro Computer (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smci#NASDAQ">SMCI</a>), and Arm Holdings (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arm#NASDAQ">ARM</a>) were victims of carnage in the tech sector last week. However, before the correction, each had gone on tremendous bull runs. In other words, some digestion is expected and warranted at this juncture. Meanwhile, Ryan Detrick of Carson Research points out that, &quot;The S&amp;P 500 has a max pullback of 5.5% in 2024 so far. Since 1980, only 4 years saw a smaller pullback. The average year since 1980 saw a 14.2% max pullback.&quot; Investors should reach the conclusion that even though the recent pullback may have felt painful, it would be normal for stocks to retreat further and still maintain their bull trend.
Bottom Line
Savvy investors understand that choppy, trendless markets are the most dangerous. Five indicators suggest a choppy market ahead.
<a href="https://www.zacks.com/commentary/2260411/cracking-the-code-5-reasons-a-choppy-market-looms?cid=CS-BENZ-FT-investment_ideas-2260411">To read this article on Zacks.com click here.</a>

CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) has outperformed the market over the past 20 years by 3.72% on an annualized basis producing an average annual return of 11.41%. Currently, CME Gr has a market capitalization of $74.34 billion. 
Buying $100 In CME: If an investor had bought $100 of CME stock 20 years ago, it would be worth $880.89 today based on a price of $206.48 for CME at the time of writing.
<h3>CME Gr's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1713301232_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In This Stock 20 Years Ago Would Be Worth $900 Today

CME Group, the world&#39;s leading derivatives marketplace, today announced that its quarterly international average daily volume (ADV) reached a record 7.4 million contracts in&nbsp;Q1&nbsp;2024, up&nbsp;2%&nbsp;year on year.&nbsp; Reflecting all trading reported from outside&nbsp;the United States, volume was driven largely by&nbsp;38%&nbsp;growth in energy products, a&nbsp;29%&nbsp;increase in agricultural products, and&nbsp;7%&nbsp;growth in metals. &nbsp;&nbsp;

CME Group International Average Daily Volume Reached Quarterly Record of 7.4M Contracts in Q1 2024

Morgan Stanley analyst Mike Cyprys maintains CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Equal-Weight and raises the price target from $222 to $225.

Morgan Stanley Maintains Equal-Weight on CME Gr, Raises Price Target to $225

Markets are preparing for the coming interest rate cycle proposed by the Federal Reserve (the Fed). Though most sectors have priced in this potential pivot, some have yet to reflect this trend higher. Over the past six months, the Consumer Discretionary Select Sector SPDR Fund (ARCA:XLY) underperformed the broader S&amp;P 500 by as much as 11%.
Other sectors, such as technology stocks, outperformed the S&amp;P by more than 5% during this period. Led by the all-time highs in names like Nvidia Cor. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvda#NASDAQ">NVDA</a>), this cyclical shift has left much room for consumer discretionary stocks to catch up.
With U.S. consumer sentiment reaching levels not seen since 2021, Wall Street institutions like The Goldman Sachs Group Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gs#NYSE">GS</a>) and the Vanguard Group saw fit to investigate the space. After bumping its position in PriceSmart Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/psmt#NASDAQ">PSMT</a>) by 14.9% in the past quarter, Goldman&#39;s $2.2 million investment gives Main Street lots to consider.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<h2>PriceSmart: A Costco in Disguise </h2>
While not as big as its primary business model competitor, Costco Wholesale Co. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cost#NASDAQ">COST</a>), PriceSmart&#39;s $2.5 billion market capitalization allows it to grow much faster than Costo and its $316 billion capitalization.
Investors can see this play out in both companies&#39; financial quarters. Costco reported sales growth of 6% in the second quarter of 2024, while PriceSmart&#39;s earnings presentation shows growth of 10.7% during the past 12 months.
Money managers may shift their preferences to stocks that offer above-average growth in the coming quarters. Because traders think that the Fed could cut interest rates in May or June 2024, a trend spotted in the FedWatch tool offered by the CME Group Inc.&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cme#NASDAQ">CME</a>), the window for preferential treatment is closing.
What is better than a stock offering discretionary and consumer staples products? A stock that does all that can still grow its earnings per share (EPS) by 19% over the next 12 months. Because PriceSmart&#39;s business model is relatively interchangeable with Costco&#39;s, Wall Street may prefer this EPS growth over Costco&#39;s 9.4%.
This EPS gap could be one reason PriceSmart stock outperformed Costco by nearly 6% over the past 3 months. Also, markets think it could keep going higher to break out of its $75 to $85 price channel.
Price action considered, PriceSmart pushed out an 18.2% rally in the past year. In comparison, the variety store industry only managed to increase by 2.3%.
<h2>Valuations Could Use a Boost </h2>
On a price-to-book ratio spread, PriceSmart becomes the most attractive buy target. The stock&#39;s 2.4x P/B ratio falls into an 85% discount to Costco&#39;s 15.6x valuation despite being set to grow its EPS by more than double the rate.
Another worthy mention in the space is Target Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tgt#NYSE">TGT</a>), which can be bought at a 6.1x P/B ratio. This valuation gives PriceSmart the upper hand, as it is discounted by 61% to Target&#39;s multiple.
There is a clear reason for this discount, which is also the same reason PriceSmart&#39;s valuation could be higher. According to the company&#39;s financials, Target&#39;s gross margins are 27%. PriceSmart, which sacrifices profits to serve a larger audience, operates on gross margins of 17% only.
Of course, this dynamic would make Target a better proposition any day, but these aren&#39;t regular times. As more and more Americans battle with <a href="https://www.msn.com/en-us/money/markets/fed-s-goolsbee-says-hot-inflation-readings-should-not-knock-us-off-path-back-to-2-target/ar-BB1l5mku">stubborn inflation</a>, alternative shopping places like PriceSmart could become the answer anyone is looking for.
Thinking the stock could see better days, the Vanguard Group joined Goldman in its 4.5% boost to its PriceSmart position, approximately $11.3 million as of March 2024.
As the volatility index (VIX) broke out to above 16%, a level not seen since October 2023, investors could be starting a &lsquo;risk off&#39; rotation, giving PriceSmart&#39;s model an opportunity to rise to the occasion and beat its much larger peers.
Because PriceSmart operates in a relatively noncyclical sector but is still set to grow its EPS above the 13% average for the space, short interest on the stock declined by 9% in the past month.
The stock now trades at a new 52-week high and is flirting with prices not seen since 2022 for what could become a more extended uptrend. Because the company reported 18% EPS growth in the latest quarter, analyst projections for 19% could potentially set the stock up for an earnings beat, the speculative thesis behind Wall Street&#39;s buying.
The article &quot;<a href="https://www.marketbeat.com/stock-ideas/institutions-think-this-consumer-stock-could-break-higher/">Institutions Think This Consumer Stock Could Break Higher</a>&quot; first appeared on MarketBeat.

UK Telegraph
&nbsp;
<a href="https://www.telegraph.co.uk/business/2024/04/08/shell-threatens-to-quit-london-for-new-york/" title="https://www.telegraph.co.uk/business/2024/04/08/shell-threatens-to-quit-london-for-new-york/">https://www.telegraph.co.uk/business/2024/04/08/shell-threatens-to-quit-london-for-new-york/</a>

NDAQ

SHEL

Shell Considers New York Listing

Barclays analyst Benjamin Budish maintains CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Equal-Weight and raises the price target from $225 to $226.

Barclays Maintains Equal-Weight on CME Gr, Raises Price Target to $226

Deutsche Bank analyst Brian Bedell downgrades CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) from Buy to Hold and lowers the price target from $235 to $210.

Downgrades

Deutsche Bank Downgrades CME Gr to Hold, Lowers Price Target to $210

Discount brokerages are here to stay, and Robinhood Markets Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hood#NASDAQ">HOOD</a>) is one of the few that has earned the public&#39;s heart, not to mention its capital. The company keeps adding new features to its platform, which was once considered for amateurs only. It now competes with The Charles Schwab Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/schw#NYSE">SCHW</a>) and others.
With the Federal Reserve (the Fed) looking to cut interest rates this year, financial stocks could soon lead the market into another leg higher. However, not all stocks in the sector are made equal. Robinhood has a unique advantage in making money from a younger, less wealthy audience, but there is a caveat.
In the United States, consumer sentiment readings have reached levels not seen since 2021. With this confidence comes new spending habits, along with looser budgets. Knowing this, Robinhood&#39;s management rolled out the platform&#39;s latest product: A credit card. Call option traders swept in not long after to go long on the potential upside.
<h2>Perfect Timing by Robinhood</h2>
Traders priced in these potential interest rate cuts to come in by May or June 2024, a trend investors can follow through the FedWatch tool at the CME Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cme#NASDAQ">CME</a>). This time window is now closing, meaning that Wall Street could be looking for the best places to rotate investment dollars.
The financial sector could be one such place, as the Financial Select Sector SPDR Fund&nbsp;(ARCA:XLF)&nbsp;outperformed the broader S&amp;P 500 by more than 5% over the past 6 months. Momentum favors the bold, and expectations for Robinhood&#39;s earnings per share (EPS) remain so.
Analysts now predict that EPS could grow by as much as 30% in the next 12 months, which is above the security brokers &amp; dealers industry average of 20%. Growing 10% faster than the industry is no small achievement for a $13.7 billion company, but it has its merits.
With strengthening consumer financing trends ahead, new sign-ups for Robinhood&#39;s credit card may come pouring in. Because members need to have &quot;gold&quot; status, this also comes with a stream of recurring (subscription-based) revenue for the platform.
<h2>Wall Street Agrees, Robinhood&#39;s a Winner</h2>
Markets are typically picky about which stocks become outliers, and Robinhood stock is one of them. From a valuation standpoint, the stock trades at a forward price-to-earnings (forward P/E) ratio of 76.8x, which is above the security brokers and dealers industry&#39;s 13.4x multiple.
Why would markets pay a 474% premium for a comparable stock? Perhaps the knowledge that a growing waitlist for the new credit card will bring EPS projections to reality.
More than that, analysts at the JMP Group LLC&nbsp;and KeyCorp (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/key#NYSE">KEY</a>) boosted their price targets for Robinhood stock. JMP thinks Robinhood could go as high as $25 a share, calling for 30% upside from where it trades today.
KeyCorp has a similar 15% upside target on the stock, as it placed a $22 price target on it. As the stock trades at 93% of its 52-week high, investors can count Robinhood as a momentum trade.
Next to one of its biggest competitors in the discount brokerage space, Charles Schwab, Robinhood also looks like a clear winner. Because Schwab stock trades at 16.1x, a nearly 80% discount to Robinhood.
The saying &quot;It must be expensive for a reason&quot; applies here; one reason could be how Robinhood has adapted to the growing base of Gen-Z investors that Schwab hasn&#39;t been able to quite capture.
<h2>Numbers Drew Traders In</h2>
Robinhood&#39;s financials during the fourth quarter show a strong trend in the right direction. Revenues advanced by as much as 37% over the past 12 months, whereas Schwab eked out mid single-digits revenue growth in their past quarter. Fundamentally, Robinhood has the upper hand.
Another way to compare these two competitors is through how much they are trusted with or assets under management. Robinhood grew its assets under custody by 65% over the past year, a figure that does not yet reflect the potential benefits of the new retail products rolled out.
Schwab only grew its assets under custody by 20% over the year. While not a negative for the $120 billion behemoth, the growth story may be found in Robinhood instead.
All of these trends made the perfect storm for call option traders to sweep in. MarketBeat&#39;s unusual call option scanner caught a spike in volume for Robinhood after the credit card announcement was made, implying that participants may already be behind this coming upswing.
The article &quot;<a href="https://www.marketbeat.com/stock-ideas/robinhoods-credit-card-has-call-option-buyers-coming-in-hot/">Robinhood&#39;s Credit Card Has Call Option Buyers Coming in Hot</a>&quot; first appeared on MarketBeat.

HOOD

SCHW

Robinhood's Credit Card Has Call Option Buyers Coming in Hot

The momentum trade has been exhausted by the large-capitalization stocks in the market, especially those in the technology sector, as names like Nvidia Co. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvda#NASDAQ">NVDA</a>) keep making new all-time highs. For this reason, quants at PGIM believe that Wall Street may soon rotate into small-capitalization stocks to squeeze further returns.
As the soldiers follow the general, stocks like SolarEdge Technologies Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sedg#NASDAQ">SEDG</a>), AB Electrolux (OTC: <a class="ticker" href="https://www.benzinga.com/stock/eluxy#OTC">ELUXY</a>), and even Antero Resources Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ar#NYSE">AR</a>) were once falling behind and could now catch up to the broader indexes. Each was tied to its own set of economic tailwinds, and analysts and institutions had enough reasons to boost and buy them.
Small businesses tend to outperform bigger ones during easing economic cycles. Now that the Federal Reserve (the Fed) is looking to cut interest rates in 2024, these small-capitalization names could help retail investors expand their wealth on the next wave of economic activity.
<h2>SolarEdge: Oil&#39;s Ugly Cousin </h2>
Oil prices have finally broken out of their $80 a barrel ceiling, and analysts at The Goldman Sachs Group Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gs#NYSE">GS</a>) believe it could go as high as $100 a barrel this year.
Because the Fed could likely cut interest rates by May or June 2024, or so do traders think, according to the FedWatch tool in the CME Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cme#NASDAQ">CME</a>), commodities like oil are advancing in the expectation of an economic breakout.
While most may run to energy stocks, others could spot the spillover opportunity in green energy stocks like SolarEdge. When oil becomes more expensive, alternative energy sources like solar become more attractive, which is where this stock comes into play.
There must be a reason why analysts think its earnings per share (EPS) could grow by as much as 330% over the next 12 months. EPS typically drives stock prices and valuations; SolarEdge stock trades at only 22% of its 52-week high despite these growth projections, a gap to be filled by investors with enough stomach to buy a small name.
Those at The PNC Financial Services Group Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pnc#NYSE">PNC</a>) had enough stomach, increasing their stock position by 41.5%, a roughly $585,000 purchase.
More than that, analysts now have a $109 price target on the stock, calling for 55% upside from today&#39;s prices.
<h2>The Buffett Effect Hits Electrolux</h2>
Interest rate cuts could also affect the future trends in mortgage rates. Historically, mortgage rates (namely the fixed 30-year rate) follow the overall credit market, where the Fed&#39;s interest rate reigns king.
Betting on the spur of new construction activity, as a result of added real estate demand from more accessible financing, Buffett bought homebuilding stocks like D.R. Horton Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dhi#NYSE">DHI</a>) and others.
New homes put up for sale typically bring appliances with them, whether it is in the kitchen or others like air conditioning. With 35% of its sales coming from the North American market, Electrolux could represent a viable way for investors to ride the side effects of this real estate boom.
This could be one of the reasons why Wall Street analysts expect more than 1,000% growth in earnings per share (EPS) in Electrolux for the next 12 months.
More than that, the stock trades at only 50% of its 52-week high, which happens to be a price not seen since the financial crisis of 2008; even with this bearish momentum as of late, short interest in the stock dropped by 62.5% in the past month, opening the way for new buyers to come in.
<h2>Antero Leading in Oil&#39;s High </h2>
The same oil trends helping renewable energy stocks like SolarEdge are the ones that could bring Antero Resources higher. Oil is now trading at $85 a barrel, a price not seen since October 2023, bringing the cost of Antero stock back to its October 2023 levels.
At 96% of its 52-week high, the stock could break into a new prolonged uptrend if oil prices allow further expansion. Analysts and their 580% EPS growth projections could make this upward path a reality by showing Main Street where the juice is.
As of March 2024, J.P. Morgan Chase &amp; Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jpm#NYSE">JPM</a>) boosted their price targets for Antero stock to $32 a share, shooting for nearly 10% upside from today&#39;s prices. Since oil has risen significantly since that last boost, investors could expect another round.
Being the macro asset manager it is, the Vanguard Group increased its position in Antero by 0.6% in the last quarter, a roughly $3.7 million purchase.
The article &quot;<a href="https://www.marketbeat.com/stock-ideas/banks-think-small-cap-stocks-need-to-catch-up-3-winners/">Banks Think Small Cap Stocks Need to Catch Up: 3 Winners</a>&quot; first appeared on MarketBeat.

AB Electrolux Class B American Depositary Receipts

ELUXY

SEDG

Banks Think Small Cap Stocks Need to Catch Up: 3 Winners

During the last three months, 4 analysts shared their evaluations of CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>), revealing diverse outlooks from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $230.25, a high estimate of $245.00, and a low estimate of $222.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 0.03%. 
<img src="https://www.benzinga.com/files/images/story/2024/1712178029_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive CME Gr. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Kyle Voigt</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Maintains</td>
<td>Market Perform</td>
<td>$229.00</td>
<td>-</td>
</tr>
<tr>
<td>Kevin Heal</td>
<td>Argus Research</td>
<td>Raises</td>
<td>Buy</td>
<td>$245.00</td>
<td>$225.00</td>
</tr>
<tr>
<td>Benjamin Budish</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$225.00</td>
<td>$222.00</td>
</tr>
<tr>
<td>Benjamin Budish</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$222.00</td>
<td>$244.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to CME Gr. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of CME Gr compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of CME Gr's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
For valuable insights into CME Gr's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/CME/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on CME Gr analyst ratings.</a>
<h2>Unveiling the Story Behind CME Gr</h2>
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The CME was founded in 1898 and in 2002 completed its initial public offering. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival, CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&amp;P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&amp;P futures contracts. Through CME's acquisition of NEX in 2018, it has also expanded into cash foreign exchange, fixed income trading, and collateral optimization.
<h3>CME Gr: Delving into Financials</h3>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Positive Revenue Trend: Examining CME Gr's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 19.17% as of 31 December, 2023, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 55.88%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): CME Gr's ROE stands out, surpassing industry averages. With an impressive ROE of 2.93%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): CME Gr's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 0.63%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: CME Gr's debt-to-equity ratio is below the industry average at 0.13, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Analyst Ratings: Simplified</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Scoreboard: 4 Ratings For CME Gr

Not A Millionaire? No Problem! Here's A 10-Stock Portfolio To Retire Comfortably

Notable earnings before Wednesday's open

CME Q1 2024 Earnings Preview

CME Non-GAAP EPS of $2.50 beats by $0.05, revenue of $1.5B beats by $20M

CME Group Q1 earnings beat consensus, as clearing and transaction fees rise

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
CME Gr (NASDAQ:<a href="https://investorplace.com/stock-quotes/cme-stock-quote/">CME</a>) just reported results for the first quarter of 2024.<ul><li>CME Gr reported earnings per share of $2.50. This was above the analyst estimate for EPS of $2.45.</li><li>The company reported revenue of $1.49 billion.</li><li>This was 0.54% better than the analyst estimate for revenue of $1.48 billion.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/04/cme-stock-earnings-cme-gr-for-q1-of-2024/">CME Stock Earnings: CME Gr Beats EPS, Beats Revenue for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

CME Stock Earnings: CME Gr Beats EPS, Beats Revenue for Q1 2024

CME Group (CME) Q1 2024 Earnings Call Transcript

In a report released yesterday, Kyle Voigt from KBW maintained a Hold rating on CME Group (CME – Research Report), with a price target of $226.00. ...

KBW Reaffirms Their Hold Rating on CME Group (CME)

There's a lot to be optimistic about in the Financial sector as 2 analysts just weighed in on CME Group (CME – Research Report) and Synchrony Finan...

-

-

-

-

-

-

-

-

-

-

-

-

-

-

CME Gr Stock (NASDAQ:CME), Short Interest Report

People Also Watch